The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer
Gastric cancer (GC) cases are predicted to rise by 2040 to approximately 1.8 million cases, while GC-caused deaths to 1.3 million yearly worldwide. To change this prognosis, there is a need to improve the diagnosis of GC patients because this deadly malignancy is usually detected at an advanced stag...
Main Authors: | Elżbieta Pawluczuk, Marta Łukaszewicz-Zając, Barbara Mroczko |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/10/8833 |
Similar Items
-
The Role of Chemokines in the Development of Gastric Cancer—Diagnostic and Therapeutic Implications
by: Elzbieta Pawluczuk, et al.
Published: (2020-11-01) -
Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer
by: Elżbieta Pawluczuk, et al.
Published: (2021-10-01) -
Clinical significance of serum levels of matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor (TIMP-2) in gastric cancer
by: Maciej Szmitkowski, et al.
Published: (2011-04-01) -
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
by: Gokul Raj Kathamuthu, et al.
Published: (2020-03-01) -
Circulating Tissue Inhibitor of Metalloproteinase-4 levels are not a Predictor of Preeclampsia in the period between 20 and 25 Weeks of Gestation
by: Valeria Cristina Sandrim, et al.
Published: (2018-12-01)